Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

Christelle Vauloup‐Fellous, Sarah Maylin, Claire Périllaud-Dubois, Ségolène Brichler, Chakib Alloui, Emmanuel Gordien, Marie‐Anne Rameix‐Welti, Elyanne Gault, Frédérique Moreau, Slim Fourati, Dominique Challine, Jean–Michel Pawlotsky, Nadhira Houhou‐Fidouh, Florence Damond, Vincent Mackiewicz, Charlotte Charpentier, Jean–François Méritet, Flore Rozenberg, Isabelle Podglajen, Stéphane Marot, Héloïse Petit, Sonia Burrel, Sepideh Akhavan, Marianne Leruez‐Ville, Véronique Avettand-Fènoël, Jacques Fourgeaud, Tiffany Guilleminot, Elise Gardiennet, Stéphane Bonacorsi, Agnès Carol, Guislaine Carcelain, Juliette Villemonteix, Narjis Boukli, Joël Gozlan, Laurence Morand‐Joubert, Jérôme LeGoff, Constance Delaugerre, Marie‐Laure Chaix, Ana-Maria Roque-Afonso, Laurent Dortet, Thierry Naas, Jean‐Baptiste Ronat, Samuel Lepape, Anne‐Geneviève Marcelin, Diane Descamps

2021European Journal of Clinical Microbiology & Infectious Diseases19 citationsDOI Open Access PDF

Topics & Concepts

SerologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakMedical microbiologyPandemicVirologyImmunologyInternal medicineAntibodyDiseaseOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies